Background {#Sec1}
==========

Osteoarthritis (OA) is the most prevalent form of arthritis in the worldwide and is regarded as a disorder of the whole joint \[[@CR1], [@CR2]\]. One of the most frequently affected joints is the knee, with a prevalence of 30% in those over 65 years old \[[@CR3]\]. There is a strong genetic component of OA with heritability estimates showing that genetic components account for 39-65% of the risk for the development of knee OA \[[@CR2], [@CR4], [@CR5]\]. However, the identification of specific genes has been problematic with some genes associated with pain \[[@CR6], [@CR7]\] and others with joint structures \[[@CR8]\]. Overall, there is a lack of consistency of associations.

One of the most comprehensively studied candidate genes is growth differentiation factor 5 (GDF5). GDF5, also known as cartilage-derived morphogenetic protein 1, is a member of the transforming growth factor-β superfamily and closely correlated with bone morphogenetic proteins. GDF5 has been shown to be involved in musculoskeletal processes including the development, maintenance and repair of bone, cartilage and other tissues of synovial joint as well as tendon \[[@CR9], [@CR10]\]. In light of the important functions of GDF5, any changes affecting a reduction in the expression of this protein could increase the risk of OA.

GDF5 mutations in humans have been implicated in several disorders of skeletal development \[[@CR11]\]. Single-nucleotide polymorphisms (SNPs) have been identified in the 5′-untranslated region (5′-UTR) of GDF5 which is involved in the regulation of GDF5 transcriptional activity \[[@CR12]\]. As for one of the most common polymorphisms (rs143383), T to C substitution in the promoter region of GDF5 has an effect on the expression of GDF5 production, with lower GDF5 expression of the OA-associated T allele \[[@CR13]\]. Several studies have suggested that GDF5 rs143383 polymorphism may be related to an elevated risk of OA in certain ethnic groups \[[@CR12], [@CR14]--[@CR16]\]. However, these positive associations have not been consistently replicated. For instance, two studies from Korea and Greece failed to detect any association with knee OA \[[@CR17], [@CR18]\]. Two earlier meta-analyses suggested that an increase in the risk of knee OA was associated with GDF5 rs143383 polymorphism in Asians and Caucasians \[[@CR11], [@CR19]\]. Since then, multiple studies on the relationship of knee OA with GDF5 have been published. Therefore, the aim of this study was to determine the overall association between GDF5 rs143383 polymorphism and knee OA risk and whether the association varies by ethnicity.

Methods {#Sec2}
=======

Literature search strategy {#Sec3}
--------------------------

We searched Medline, Embase and ISI Web of science databases for all English articles on the association between GDF5 gene promoter polymorphism and OA (last report up to 13 July 2013). Combinations of keywords used in the search were: ("Growth differentiation factor 5" or "GDF5" or "rs143383" or "+104 T/C"), ("polymorphism" or "polymorphisms") and ("osteoarthritis" or "OA"). References of retrieved studies and review articles were also screened for other additional eligible publications and unpublished studies. Conference abstracts were not considered.

Inclusion and exclusion criteria {#Sec4}
--------------------------------

All studies included in this meta-analysis had to meet the following criteria: (1) the type of study was a case--control or cohort study; (2) a study investigated the association of GDF5 (rs143383; +104 T/C) polymorphism with knee OA; (3) available alleles or genotypes frequencies of GDF5 were provided to evaluate the odds ratios (ORs) with 95% confidence intervals (CIs). The exclusion criteria were as follows: (1) the study was not conducted on knee OA; (2) the study was conducted on animals or cells; (3) the data could not be extracted after contacting with the authors.

Data extraction {#Sec5}
---------------

All data were extracted independently from eligible studies by two reviewers (Pan and Tian) according to the criteria listed above. The following information were collected: the first author's name, publication date, country of origin, study design, ethnicity, total sample size of cases and controls, genotype and allele frequencies of cases and controls, sources of controls, age, sex and genotyping method, which also were reviewed by a third investigator (Jones). We also extracted data on how knee OA was defined i.e. clinical criteria, radiographic criteria, or total knee replacement (TKR). For clinical criteria, the American College of Rheumatology (ACR) criteria was used if information on ACR was available \[[@CR20]\]. For radiographic criteria, Kellgren/Lawrence (K/L) score (0--4 scale) was used to identify and grade knee OA. A cut-off of K/L score 2 was used to be a classification of knee OA \[[@CR21]\]. Any controversies about interpretation of data were discussed within our research team to reach a consensus. In cases where the same patient population was included in different studies, only the larger sample size was included in this meta-analysis. If one study contains the results from different populations, each group was treated independently. Authors were contacted where unpublished data or clarification were needed.

Statistical methods {#Sec6}
-------------------

Allele frequencies at GDF5 rs143383 polymorphism from the respective study were determined by the allele counting method. The strength of the association between GDF5 rs143383 polymorphism and knee OA susceptibility was estimated by calculating the pooled ORs with their 95% CIs. The Z-test was used to determine the significance of the pooled ORs and 95% CIs. The pooled ORs were performed for additive (C vs. T), co-dominant (CC vs. TT; CT vs. TT), dominant (CC + CT vs. TT), and recessive (CC vs. CT + TT) models. The between-study heterogeneity was assessed using the Chi square based Q-statistic \[[@CR22]\]. If a *P* value less than 0.10 for the *Q*-test was observed, it indicates the presence of heterogeneity among studies \[[@CR23]\]. The *I*^*2*^ statistic (*I*^*2*^ = 100% × (*Q*-df)/*Q*) was also used to quantify heterogeneity. *I*^*2*^ ranges from 0 to 100% which is interpreted as the degree of inconsistency across studies \[[@CR24]\]. An *I*^*2*^ greater than 50% was considered as heterogeneity among studies. The random-effect model was used to determine the pooled ORs. Sensitivity analysis was performed by excluding the Hardy-Weinberg equilibrium (HWE)-violating studies \[[@CR25]\]. Potential publication bias was assessed by the funnel plot, in which the standard error of log (OR) of each study was plotted against its log (OR). A symmetric plot indicates a low risk of publication bias. If visual inspection suggested there was funnel plot asymmetry, the method of Egger's linear regression test was used to further assess \[[@CR26]\]. All statistical analyses were carried out using STATA version 7.0 (Stata Corporation, College Station, TX). Two-sided *P* \<0.05 was considered to be statistically significant.

Results {#Sec7}
=======

Characteristics of included studies {#Sec8}
-----------------------------------

A total of 12 articles were identified \[[@CR11], [@CR12], [@CR14]--[@CR19], [@CR27]--[@CR30]\]. Among these, one article \[[@CR12]\] reported on a Japanese population and a Chinese population, these were considered as two separate studies. Two other studies performed by Southam et al. \[[@CR14]\] and Valdes et al. \[[@CR27]\] also included two independent studies, the former contained UK and Spanish studies, and the latter investigated two different populations in the UK. In addition, the three previous meta-analyses included unpublished data from independent studies \[[@CR11], [@CR19], [@CR30]\] where only T allele and C allele counts can be extracted from the Twins UK and Finnish study \[[@CR19]\], and the Rotterdam study III \[[@CR30]\]. Thus, 20 studies with 8,709 cases and 15,286 controls were included in the current meta-analysis. The study flow chart is shown in Figure [1](#Fig1){ref-type="fig"}. Detailed characteristics of these studies are listed in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}. Of eligible studies, 6 studies (n = 6,219) and 14 studies (n = 17,776) were conducted respectively in Asian and Caucasian populations. Male and female subgroups were available from 5 studies in Asian and 4 studies in Caucasian population.Figure 1**Flow diagram of the study selection process.** ^a^P: population group; E: exposure; C: control group; O: outcome; S: study design.

###### 

**Characteristics of individual studies included in meta-analysis**

  First author    Year   Country       Study design         Ethnicity   Sample size   Source of controls   Genotyping method   Age (mean)                                                  Knee OA definition                            
  --------------- ------ ------------- -------------------- ----------- ------------- -------------------- ------------------- ----------------------------------------------------------- -------------------- -------- ------- ------- -------
  Southam^a^      2007   UK            Case--control        Caucasian   349           822                  HB                  PCR-RFLP                                                    65                   69                       **+**
  Southam^b^      2007   Spain         Case--control        Caucasian   274           1196                 HB                  TaqMan                                                      NA                   \>55.0                   **+**
  Miyamoto^a^     2007   Japan         Case--control        Asian       718           861                  HB                  TaqMan, Invader, DNA fragment analysis or Direct sequence   71.9                 49.4     **+**           
  Miyamoto^b^     2007   China         Case--control        Asian       313           485                  HB                  TaqMan, Invader, DNA fragment analysis or Direct sequence   58.8                 56.8     **+**           
  Tsezou          2007   Greece        Case--control        Caucasian   251           268                  HB                  Direct sequence                                             67.9                 65.2     **+**           
  Chapman         2008   Netherlands   Cohort study         Caucasian   142           724                  PB                  Mass spectrometry                                           60.4                 59.6     **+**           
  Valdes^a^       2009   UK            Case--control        Caucasian   735           654                  HB                  Allele-specific PCR                                         68.5                 66.9             **+**   
  Valdes^b^       2009   UK            Cohort study         Caucasian   264           512                  PB                  Allele-specific PCR                                         66.3                 63       **+**           
  Vaes            2009   Netherlands   Cohort study         Caucasian   667           2097                 PB                  TaqMan                                                      \>55.0               \>55.0   **+**           
  Evangelou^a^    2009   Iceland       Cohort study         Caucasian   1071          1169                 PB                  Centaurus platform                                          74.8                 74.8                     **+**
  Evangelou^b^    2009   UK            Twins study          Caucasian   177           548                  NA                  Illumina platform                                           54.3                 54.3     **+**           
  Evangelou^c^    2009   Finland       Family-based study   Caucasian   109           209                  NA                  Mass spectrometry                                           67                   58       **+**           **+**
  Cao             2010   Korea         Case--control        Asian       276           298                  PB                  PCR-RFLP                                                    63                   44                       **+**
  Tawonsawatruk   2011   Thailand      Case--control        Asian       103           103                  HB                  PCR-RFLP                                                    68.5                 59.25                    **+**
  Valde^a^        2011   UK            Cohort study         Caucasian   867           758                  PB                  Allele-specific PCR                                         66.5                 66.5                     **+**
  Valdes^b^       2011   Estonian      Cohort study         Caucasian   65            427                  PB                  Allele-specific PCR                                         47.1                 47.1     **+**           
  Valdes^c^       2011   UK            Cohort study         Caucasian   1141          536                  PB                  Allele-specific PCR                                         65.5                 65.5     **+**           **+**
  Valdes^d^       2011   Netherlands   Cohort study         Caucasian   162           1582                 PB                  TaqMan                                                      \>45.0               \>45.0   **+**           
  Shin            2012   Korea         Cohort study         Asian       725           1737                 PB                  High resolution melting analysis                            67.4                 62.7     **+**           
  Mhishra         2013   India         Case--control        Asian       300           300                  HB                  PCR-RFLP                                                    54.0                 55.2     **+**   **+**   

^a,b,c^ and ^d^Denote an independent study in the one article, respectively; NA Data not available; HB hospital-based; PB population-based; PCR-RFLP polymerase chain reaction restriction fragment length polymorphism; TKR total knee replacement.

\*Radiographic criteria (Kellgren/Lawrence grade ≥2).

^†^Clinical criteria are based on the American College of Rheumatology.

###### 

**Distributions of GDF5 rs143383 genotypes and alleles among cases and controls**

  First author    Year   Case   Control   Case   Control   ***P*** ^***HWE***^                                    
  --------------- ------ ------ --------- ------ --------- --------------------- ----- ------ ----- ------ ------ -------
  Southam^a^      2007   141    168       40     324       372                   126   450    248   1020   624    0.262
  Southam^b^      2007   102    136       36     439       563                   194   340    208   1441   951    0.550
  Miyamoto^a^     2007   444    243       31     473       330                   58    1131   305   1276   446    0.966
  Miyamoto^b^     2007   197    97        19     244       193                   48    491    135   681    289    0.283
  Tsezou          2007   95     126       30     99        125                   44    316    186   323    213    0.669
  Chapman         2008   54     72        16     289       331                   104   180    104   909    539    0.558
  Valdes^a^       2009   337    313       85     238       329                   79    987    483   805    487    0.032
  Valdes^b^       2009   126    98        35     181       244                   84    350    168   606    412    0.908
  Vaes            2009   276    298       93     752       1014                  331   850    484   2518   1617   0.724
  Evangelou^a^    2009   535    379       157    552       442                   175   1449   693   1546   792    0.000
  Evangelou^b^    2009   NA     NA        NA     NA        NA                    NA    230    124   679    417    NA
  Evangelou^c^    2009   NA     NA        NA     NA        NA                    NA    124    94    251    167    NA
  Cao             2010   150    115       11     159       113                   26    415    137   431    165    0.360
  Tawonsawatruk   2011   38     41        11     33        47                    23    117    63    113    93     0.424
  Valdes^a^       2011   413    361       93     294       354                   110   1187   547   942    574    0.837
  Valdes^b^       2011   32     24        9      168       179                   80    88     42    515    339    0.010
  Valdes^c^       2011   467    511       163    219       237                   80    1445   837   675    397    0.229
  Valdes^d^       2011   NA     NA        NA     NA        NA                    NA    195    107   1930   1234   NA
  Shin            2012   382    305       38     942       689                   106   1069   381   2573   901    0.176
  Mhishra         2013   124    130       46     84        160                   56    378    222   328    272    0.188

^a,b,c^ and ^d^Denote an independent study in the one article, respectively; HWE Hardy-Weinberg equilibrium; NA Data not available.

Quantitative assessment {#Sec9}
-----------------------

The summary of meta-analyses for GDF5 rs143383 polymorphism with OA is shown in Table [3](#Tab3){ref-type="table"}.Table 3**Meta-analysis of GDF5 rs143383 polymorphism and knee OA**PopulationComparison (N^a^)Test of associationTest of heterogeneityOR (95% CI)***P*** ^***b***^***P*** ^***c***^***I*** ^***2***^(%)OverallC vs. T (20)0.85 (0.80-0.90)0.0000.01944.1CC vs. TT (17)0.73 (0.66-0.81)0.0000.32810.8CT vs. TT (17)0.84 (0.76-0.94)0.0020.00062.2CC/CT vs. TT (17)0.81 (0.73-0.90)0.0000.00061.7CC vs. CT/TT (17)0.81 (0.74-0.86)0.0000.6230.0EthnicityAsianC vs. T (6)0.78 (0.67-0.92)0.0030.00669.5CC vs. TT (6)0.60 (0.48-0.76)0.0000.33312.9CT vs. TT (6)0.80 (0.63-1.02)0.0710.00274.3CC/CT vs. TT (6)0.76 (0.60-0.96)0.0210.00175.8CC vs. CT/TT (6)0.68 (0.56-0.84)0.0000.4940.0CaucasianC vs. T (14)0.87 (0.82-0.92)0.0000.22920.7CC vs. TT (11)0.78 (0.70-0.87)0.0000.6110.0CT vs. TT (11)0.86 (0.76-0.97)0.0120.01156.2CC/CT vs. TT (11)0.83 (0.75-0.93)0.0010.02052.6CC vs. CT/TT (11)0.84 (0.76-0.93)0.0010.8220.0SexFemalesC vs. T (9)0.85 (0.78-0.93)0.0000.23623.3CC vs. TT (9)0.73 (0.62-0.87)0.0000.9230.0CT vs. TT (9)0.81 (0.69-0.95)0.0110.02953.2CC/CT vs. TT (9)0.80 (0.69-0.93)0.0030.03950.7CC vs. CT/TT (9)0.83 (0.70-0.97)0.0210.9900.0MalesC vs. T (9)0.85 (0.74-0.97)0.0200.17130.9CC vs. TT (9)0.65 (0.50-0.84)0.0010.4640.0CT vs. TT (9)0.99 (0.81-1.20)0.8880.13934.8CC/CT vs. TT (9)0.90 (0.74-1.09)0.2720.10739.1CC vs. CT/TT (9)0.66 (0.51-0.84)0.0010.6130.0OR odds ratio, CI confidence interval, ^a^Number of comparison, ^b^ *P* values for within group differences were determined by Z test, ^c^ *P P* value of *Q*-test for heterogeneity test.

Overall population {#Sec10}
------------------

20 separate studies had available data for analysis of GDF5 rs143383 polymorphism and knee OA risk with a total sample size of 8,709 cases and 15,286 controls. In the allele model and genotype models, significant associations were found when all studies were pooled in the overall population (Table [3](#Tab3){ref-type="table"}). The summary OR for allele model was 0.85 (95% CI = 0.80-0.90). The forest plot of the distribution of the ORs for allele model is shown in Figure [2](#Fig2){ref-type="fig"}. Similarly, the summary ORs for genotype models ranged from 0.73 to 0.84. There was substantial and statistically significant heterogeneity for CT vs. TT (*I*^*2*^ = 62.2%) and dominant model (*I*^*2*^ = 61.7%).Figure 2**Forest plot of the association of GDF5 rs143383 polymorphism with knee osteoarthritis risk under additive model (C versus T).**

Subgroup analyses by ethnicity {#Sec11}
------------------------------

Protective effects in Asian populations were consistently greater in magnitude and the associations were all statistically significant in the Asian subgroup except for CT versus TT which approached but did not reach significance (*P* = 0.071) (Table [3](#Tab3){ref-type="table"}). The summary ORs were highly significant especially for CC vs. TT (OR = 0.60, *P* \<0.001) and the recessive model (OR = 0.68, *P* \<0.001) (Figure [3](#Fig3){ref-type="fig"}). In the Asian subgroup, the between-study heterogeneity remained substantial apart from two models (CC vs. TT and the recessive model, *I*^*2*^ = 12.9% and *I*^*2*^ = 0.0%, respectively). In Caucasian populations, similar results were found under all models with weaker associations (OR = 0.78 to 0.87, all *P* \<0.05), but a lower heterogeneity was observed.Figure 3**Forest plots for statistically significant meta-analysis in Asian populations. (A)** CC versus TT; **(B)** CC versus CT/TT.

Subgroup analyses by sex {#Sec12}
------------------------

When 9 studies with a sample size of females (n = 7,203) and males (n = 4,733) were stratified by sex, there were no significant differences in effects between males and females (Table [3](#Tab3){ref-type="table"}). In females, all models showed significant associations. A stronger significant association was observed for CC vs. TT (OR = 0.73, *P* \<0.001) in comparison with other models in males, similarly, there were significant differences for CC vs. TT and recessive model in females with the strongest association being for CC vs. TT (OR = 0.65, *P* = 0.001) (Figure [4](#Fig4){ref-type="fig"}). Furthermore, not all associations were significant in males (CT vs. TT: OR = 0.99, 95% CI = 0.81-1.20; CC/CT vs. TT: OR = 0.90, 95% CI = 0.74-1.09). Intriguingly, stratification by sex reduced heterogeneity in both males and females in all models compared to that seen in the overall population. In females, substantial and statistically significant heterogeneity persisted only for CT vs. TT (*I*^*2*^ = 53.2%) and dominant models (*I*^*2*^ = 50.7%). In males, *I*^*2*^ \< 50% was observed in all models.Figure 4**Subgroup analysis by sex for knee osteoarthritis risk associated with GDF5 rs143383 polymorphism under CC versus TT model.**

Evaluation of other potential sources of heterogeneity {#Sec13}
------------------------------------------------------

In addition to evaluation of sources of heterogeneity by ethnicity and sex, we also further investigated other potential sources of heterogeneity by control types and knee OA definition (Table [4](#Tab4){ref-type="table"}). Subgroup analysis by control types found that heterogeneity of hospital-based group was partly attenuated with *I*^*2*^ = 0% for CC vs. TT and recessive model; however, significant heterogeneity still was seen in the population-based group. When stratification by knee OA definition, a significant reduction in the heterogeneity (*I*^*2*^ \< 41.0%) was observed where TKR was used to define the cases but not for those studies using radiographic criteria.Table 4**Identifying the source of heterogeneity by control type and knee OA definition**SubgroupC vs. TCC vs. TTCT vs. TTCC/CT vs. TTCC vs. CT/TT*P* ~*h*~*I* ^*2*^(%)*P* ~*h*~*I* ^*2*^(%)*P* ~*h*~*I* ^*2*^(%)*P* ~*h*~*I* ^*2*^(%)*P* ~*h*~*I* ^*2*^(%)**Source of controls**HB0.19629.10.6810.00.01360.80.03254.40.7030.0PB0.05146.60.23323.70.00662.90.00564.00.5110.0**Knee OA definition**Radiographic0.04348.30.6540.00.00368.10.00268.90.8740.0TKR0.20630.50.13241.00.18733.30.18433.60.15338.0HB hospital-based, PB population-based, TKR total knee replacement, *P* ~*h,*~ *P* value of *Q*-test for heterogeneity test.

Sensitivity analyses {#Sec14}
--------------------

Sensitivity analyses were performed by excluding the HWE-violating studies to evaluate the stability of the results. Departure from HWE was observed in the controls of three studies (Table [2](#Tab2){ref-type="table"}). After excluding these studies, the corresponding ORs did not materially alter under all models, suggesting that the results of this meta-analysis are stable (data not shown).

Evaluation of publication bias {#Sec15}
------------------------------

Begger's funnel plot was firstly performed to assess the publication bias. As shown in Figure [5](#Fig5){ref-type="fig"}, no obvious asymmetry was found by the shape of the funnel except for CC vs TT and recessive model. Egger's test was then performed for statistical test, revealing there might be publication bias under CC versus TT and recessive model.Figure 5**Funnel plot and Egger's publication bias plot for meta-analysis on association between GDF5 rs143383 polymorphism and knee osteoarthritis risk (C versus T). (A)** Begg's funnel plot for meta-analysis; **(B)** Egger's linear regression test for publication bias.

Discussion {#Sec16}
==========

To our knowledge, this is the largest and most comprehensive meta-analysis to assess the association of GDF5 rs143383 polymorphism with knee OA, including data from 20 studies in 8,709 knee OA cases and 15,286 controls. Overall analysis of pooled results demonstrated a statistically significant association between the variant genotype of GDF5 and knee OA risk in all comparisons. When stratification by ethnicity, significant associations were found in Asian as well as in Caucasian populations with a greater effect sizes in Asian population, suggesting that GDF5 rs143383 polymorphism is a determinant for knee OA risk and shared between Asian and Caucasian populations.

GDF5, an extracellular signalling molecule, plays a critical role in the development, maintenance and repair of synovial joint tissues, and it has been suggested that deficiency of GDF5 is one of the most important risk factors for the pathogenesis of OA \[[@CR10]\]. The expression of the GDF5 protein is modulated by the GDF5 gene, and rare deleterious mutations in the GDF5 gene cause several disorders of skeletal development, such as chondrodysplasias and brachydactyly, suggesting this gene has a crucial role in joint homeostasis and repair \[[@CR17]\]. Several animal models have further confirmed the evidence supporting a critical role of GDF5 \[[@CR31]--[@CR34]\]. In mice with GDF5 mutation, a number of abnormalities of joint were found including the decrease in appendicular skeleton and the limb long bones, soft tissue deformities and tendon anomaly. Taken together, these results imply that GDF5 polymorphism may have an important function in the aetiology and pathogenesis of OA.

In this study, we found that C allele of GDF5 was protective for knee OA susceptibility (OR = 0.85, 95% CI = 0.80-0.90, *P* \<0.001), and T allele of GDF5 was associated with a higher risk for knee OA development. These findings seem to be biologically plausible. The T allele of the rs143383 SNP has been shown to be associated with a reduction in GDF5 transcriptional activity, thereby increasing the risk of developing knee OA, compared with the GDF5 C allele \[[@CR12], [@CR14]\]. In the subgroup analysis by ethnicity, effects sizes were consistently greater in Asian populations as compared to Caucasian populations, indicating that the same gene polymorphism may have different roles in knee OA susceptibility among different racial backgrounds, and the difference in linkage disequilibrium patterns may exist \[[@CR19]\].

Several meta-analyses have been performed to identify the association between the GDF5 variant and knee OA risk. In a previous meta-analysis by Chapman et al. \[[@CR11]\] including 2,207 cases and 4,356 controls, a significant association of GDF5 rs143383 polymorphism with knee OA was observed in Asians as well as Caucasians. In another meta-analysis, Evangelou et al. \[[@CR19]\] included 5,085 cases and 8,135 controls and found that GDF5 rs143383 polymorphism was associated with the risk of knee OA. In the subgroup analysis, the same association was observed across different populations. Although two recent meta-analyses also suggested that GDF5 rs143383 polymorphism was associated with knee OA susceptibility, their results should be interpreted with caution \[[@CR35], [@CR36]\]. In the study performed by Liu et al. \[[@CR35]\], all OA cases were pooled into their study and subgroup analyses by joint site, ethnicity, and sex were not performed. In the study by Hao and Jin \[[@CR36]\] comprising 6 studies with 2,744 cases and 4,518 controls, there was incomplete identification of publications, which may distort the results \[[@CR37]\]. Valdes et al. \[[@CR30]\] also performed the meta-analysis with the largest sample size (7,579 cases and 11,947 controls), reporting that the T allele of the GDF5 polymorphism is associated with a 17% elevated risk for knee OA. Consistent with this, the present meta-analysis with a larger sample size showed a similar effect size of T allele for knee OA in the overall population. However, we found a slightly lower risk estimate for the T allele (OR = 1.15) in Caucasian population as compared to the Valdes' paper (OR = 1.16). This discrepancy may be due to inconsistency of reporting data from the Rotterdam I study. In the current paper, data from this study was extracted from one of the original papers reporting Rotterdam I study \[[@CR28]\] rather than from a previous meta-analysis \[[@CR19]\], thereby leading to a slight data variation. Additionally, the GDF5 polymorphism was found to be consistently associated with knee OA risk in Asian population. This further provides strong evidence of GDF5 rs143383 polymorphism to knee OA risk across different populations.

Heterogeneity is a potential problem in the understanding the results of meta-analyses. In this study, significant heterogeneity between different studies was observed in the overall population. To clarify the source of heterogeneity, ethnicity and sex were used to stratify the studies, finding part of this heterogeneity can be effectively attenuated or removed when stratification by sex. This indicates that it is important for meta-analyses of genetic association studies to perform subgroup analyses by sex. After subgroup analysis by source of controls, the heterogeneity was also decreased; therefore, it can be assumed that the heterogeneity partly results from difference of source of controls. That may be because potential confounding factors in many epidemiologic studies may result from the difference in control types \[[@CR38]\]. In addition, different studies used different criteria to define the cases, which might be one of sources of heterogeneity. Some centres defined their cases using the K/L classification and/or ACR criteria, whereas other centres used a TKR to define their cases. These differences between studies in the control group as well as key characteristics of the participants might lead to heterogeneity in the magnitude of the genetic effects \[[@CR19]\]. Therefore, a broad consensus should be reached about OA phenotype definitions and how to enrol an ideal control group. Furthermore, other factors also should be explored to identify the source of heterogeneity if more data was available.

Of note, several potential limitations of this study should be acknowledged. Firstly, knee OA is a multifactorial disease with complex associations between genetic factors and environmental factors, and is a polygenic disease that could not be conferred significantly by no loci individually \[[@CR39], [@CR40]\]. Hence, some environmental factors or other polymorphic loci should be taken into account together to arrive at a true effect of GDF5 gene. Secondly, in view of our results from unadjusted estimates, a more accurate assessment should be performed according to age, body mass index, smoking status, and other lifestyle factors if more detailed data were available. Thirdly, publication bias was found in two models, which may give rise to biased results, in particular potentially an overestimate of the effect. However, unpublished studies would need to have a large negative association to have sufficient weight to substantially change our results.

Conclusions {#Sec17}
===========

This meta-analysis suggests that GDF5 rs143383 polymorphism is highly associated with the susceptibility to knee OA with protective associations for the C allele and CC genotype across different populations.
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